Business · 27/04/2026Updated: 10/16/2026 · 1 min read
FDA Announces Public Advisory Committee Meeting for COVID-19 Vaccine Composition
Summary
The FDA is hosting a public meeting of the Vaccines and Related Biological Products Advisory Committee to discuss the 2026-2027 formula for COVID-19 vaccine composition and is seeking public comments.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →